Codegest Expectorant Interactions
There are 636 drugs known to interact with Codegest Expectorant (codeine / guaifenesin / phenylpropanolamine), along with 21 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 156 are major, 478 are moderate, and 2 are minor.
- View all 636 medications that may interact with Codegest Expectorant
- View Codegest Expectorant alcohol/food interactions (1)
- View Codegest Expectorant disease interactions (21)
Most frequently checked interactions
View interaction reports for Codegest Expectorant (codeine / guaifenesin / phenylpropanolamine) and the medicines listed below.
- acamprosate
- acetaminophen
- Afrin (oxymetazoline nasal)
- allopurinol
- alogliptin / pioglitazone
- amitriptyline
- amlodipine
- amoxicillin
- aripiprazole
- aspirin
- Banophen (diphenhydramine)
- betamethasone / clotrimazole topical
- calcium citrate
- carvedilol
- cephalexin
- cetirizine
- colchicine
- Coreg (carvedilol)
- cranberry
- cyclobenzaprine
- daptomycin
- dextromethorphan
- diazepam
- diclofenac
- Diflucan (fluconazole)
- doxycycline
- escitalopram
- gabapentin
- omeprazole
- pantoprazole
Codegest Expectorant alcohol/food interactions
There is 1 alcohol/food interaction with Codegest Expectorant (codeine / guaifenesin / phenylpropanolamine).
Codegest Expectorant disease interactions
There are 21 disease interactions with Codegest Expectorant (codeine / guaifenesin / phenylpropanolamine) which include:
- impaired GI motility
- infectious diarrhea
- prematurity
- acute alcohol intoxication
- drug dependence
- hypotension
- intracranial pressure
- respiratory depression
- gastrointestinal obstruction
- cardiovascular disease
- adrenal insufficiency
- liver disease
- renal dysfunction
- seizure disorders
- urinary retention
- arrhythmias
- biliary tract disease
- psychosis
- BPH
- diabetes
- glaucoma
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.